• Cyclezyme posted no net sales in Q2 2026, unchanged from a year earlier.
• Operating loss widened to SEK 735,000, compared with SEK 671,000 in Q2 2025.
• Loss per share deepened to SEK 0.29 from SEK 0.28 in the year-ago quarter.
• First-half net sales fell to none, from SEK 150,000 a year earlier; operating loss widened to SEK 1.56 million.
• Reported progress with Albany International on enzymatic recycling of industrial textiles, including successful depolymerization of selected samples and process optimization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclezyme AB published the original content used to generate this news brief via Cision (Ref. ID: 202608280245BITN____UKPR__SV_20260827-BIT-2923-0) on August 28, 2026, and is solely responsible for the information contained therein.